Venlafaxine HCl extended-release capsules, indicated for the treatment of major depressive disorder and generalized anxiety disorder, are the generic version of Wyeth Pharmaceutical’s Effexor XR capsules.
Currently, Mylan has 112 abbreviated new drug applications (ANDA) pending FDA approval, 23 of which are potential first-to-file opportunities.